Physician

Arathi Ramamurthi Rana, MD

According to 2025 Medicare claims, Arathi Rana, MD (NPI: 1306291125) practices dermatology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is OLIVER STREET 5.01(A) INC. (NPI: 1457695413; TIN: 461314303) and primary practice location at 75090-1770. Rana is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Rana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,533 traditional Medicare patients, billed 9,490 HCPCS/CPT codes, and received $374,531 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 931 prescription claims across 392 beneficiaries totaling $654,404 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 25 records totaling $488. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,874 to $654,404. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$212K$424K2020 Medicare payment: $49,245 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $396,026 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $424,130 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $359,283 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $374,531 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20202341,024$49,245
20211,3439,435$396,026
20221,53110,665$424,130
20231,5919,986$359,283
20241,5339,490$374,531

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$363K$726K2016 Drug cost: $5,874 (USD; Tot_Drug_Cst)2017 Drug cost: $25,034 (USD; Tot_Drug_Cst)2018 Drug cost: $23,660 (USD; Tot_Drug_Cst)2019 Drug cost: $18,017 (USD; Tot_Drug_Cst)2020 Drug cost: $45,066 (USD; Tot_Drug_Cst)2021 Drug cost: $156,641 (USD; Tot_Drug_Cst)2022 Drug cost: $557,851 (USD; Tot_Drug_Cst)2023 Drug cost: $726,011 (USD; Tot_Drug_Cst)2024 Drug cost: $654,404 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20163081$5,874
201798205$25,034
2018159297$23,660
2019173322$18,017
2020147301$45,066
2021410899$156,641
20224371,050$557,851
2023433950$726,011
2024392931$654,404

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths396458$80
11102Biopsy of related skin growth, first growth390480$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,2511,865$63
17000Destruction of precancer skin growth, 1 growth7261,061$40
17003Destruction of precancer skin growth, 2-14 growths6124,467$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab491,526$206,310
OtezlaApremilast24720$115,671
Betamethasone DipropionateBetamethasone Dipropionate872,462$4,277
Clobetasol PropionateClobetasol Propionate451,518$2,864
Triamcinolone AcetonideTriamcinolone Acetonide1915,753$2,340

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$488ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arathi Ramamurthi Rana, MD?

Tedicare shows public-source Medicare data for Arathi Ramamurthi Rana, MD (NPI 1306291125), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arathi Ramamurthi Rana, MD have ACO affiliation data?

Arathi Ramamurthi Rana, MD is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Arathi Ramamurthi Rana, MD?

Arathi Ramamurthi Rana, MD is linked to OLIVER STREET 5.01(A) INC. (billing NPI 1457695413) in the available physician profile data.

Does Arathi Ramamurthi Rana, MD have Open Payments data?

Arathi Ramamurthi Rana, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.